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INNOVATION HIGHLIGHT
Development of Adult ADHD Toolkit for Use in Collaborative 
Care
C. Jason Mallo, DO
Department of Psychiatry, Maine Medical Center, Portland, ME
Introduction:  Providers in collaborative care have been challenged to respond to rising patient complaints about 
attention deficit hyperactivity disorder (ADHD) in adulthood, and institutional guidance has been 
insufficient. To address this issue, an Adult ADHD Toolkit was created for providers in primary care and 
psychiatry. This article reviews how the toolkit was developed and what it contains, as well as future 
directions for its application.
Methods:  A workgroup of providers from different backgrounds developed materials for an adult ADHD toolkit 
based on a review of adult ADHD literature and clinical consensus.
Results:  The Adult ADHD toolkit summarizes a triage model for approaching patient complaints related to ADHD. 
It contains a handout for providers with tips for diagnosing and treating ADHD in adulthood, as well as 
in-depth information about assessing and managing the disorder. It also contains materials for patients.
Discussion:  The toolkit addresses common dilemmas encountered by providers and patients when evaluating and 
managing adult ADHD, a complex condition that requires an individualized treatment plan.
Conclusion:  More information is needed about the feasibility and implications of adapting the Adult ADHD Toolkit. Such 
information could help guide future efforts toward improving patient outcomes through a collaborative 
care model.
Keywords:  attention deficit hyperactivity disorder, adult, collaborative care, practice guidelines 
Collaborative care involves the integration of primary care and psychiatry. It is an effective treatment strategy for common mental 
health conditions, such as major depression and 
anxiety disorders.1 Less well known is how patients 
and providers in collaborative care manage more 
complex conditions, such as attention deficit 
hyperactivity disorder (ADHD) in adulthood. 
Previously relegated to the child/adolescent 
population, ADHD is now widely embraced by the 
medical community as a condition that can persist 
into adulthood.2 Characteristics of adult ADHD 
include inattention, disorganization, hyperactivity, 
and impulsiveness. ADHD affects approximately 4% 
of adults2 and can have profound consequences, 
such as academic/occupational failure, legal 
difficulties, relationship dysfunction, adverse health 
outcomes, and higher medical costs.3
The rising number of patients presenting for the 
evaluation of adult ADHD4 has posed a challenge 
to providers, many of whom feel uneasy and 
ill-prepared.5 A survey of 1,216 primary care 
physicians showed that 36% were not at all 
confident in treating ADHD in adulthood, and only 
8% were very confident.6 This issue is compounded 
by the limited availability of institutional and national 
guidelines for managing ADHD in adulthood.6 
The American Psychiatry Association, the largest 
psychiatric organization in the world, has no 
practice guidelines for ADHD7, and other existing 
guidelines emphasize treatment with stimulants at 
the expense of alternative treatment options.
In fall 2016, the Integration Support Advisory 
Committee (ISAC) at MaineHealth, which is 
dedicated to enhancing collaborative care efforts 
Correspondence: C. Jason Mallo, DO
Maine Medical Center
216 Vaughan Street, Portland, ME 04101  
cmallo@mmc.org
1
Mallo: Adult ADHD Toolkit
Published by MaineHealth Knowledge Connection, 2020
at Maine Medical Center (MMC), completed a 
needs assessment. This assessment indicated that 
primary care providers wanted help addressing 
adult ADHD. They wanted advice about best 
practices, screening tools, and knowing when to 
refer patients to behavioral health. In response, 
ISAC spearheaded the development of an Adult 
ADHD Toolkit that could be used by collaborative 
care providers in the MaineHealth system. This 
article reviews how the toolkit was created and 
what it contains, as well future directions for its 
application.
METHODS
In winter 2016, ISAC assembled a workgroup of 
providers who volunteered to develop an Adult 
ADHD Toolkit. A facilitator organized and oversaw 
the project. The intent of the toolkit was to help 
providers manage the complexities of ADHD in 
adulthood and establish practice standards within a 
collaborative care model. The workgroup consisted 
of 8 MMC providers representing psychiatry, 
neuropsychology, psychology, social work, and 
primary care. Other specialties (e.g., pharmacy) 
were consulted as needed.
Between January 2017 and June 2017, the 
workgroup met 6 times to discuss the format of 
the toolkit, essential assessment and treatment 
recommendations, and the advantages/
disadvantages of different rating scales for 
assessment and monitoring. The workgroup also 
established a triage model for addressing patient 
concerns, as well as definitions for the roles of 
collaborative care providers.
Materials in the toolkit were original and generated 
based on a literature review and clinical consensus. 
Workgroup members examined selected 
publications, including articles in peer-reviewed 
journals,2,8,9,10,11 textbooks by leaders in the field of 
ADHD,12,13 and available national guidelines.14
The facilitator summarized workgroup discussions 
in the original draft of the Adult ADHD Toolkit. Later 
drafts were edited between June 2017 and April 
2019 based on feedback from ISAC and workgroup 
members. An area of disagreement that arose while 
editing the toolkit was wording around stimulants 
being a superior treatment option. The members 
reached consensus on the matter, emphasizing the 
use of alternative treatments, the need for careful 
screening and monitoring with stimulants, and the 
importance of using functional outcomes.
Currently, the toolkit is being implemented through 
in-service meetings with collaborative care 
providers at MMC. It is being distributed through 
printed copies and electronically via the MMC 
intranet.
RESULTS
Collaborative care providers do not have to read 
the entire Adult ADHD Toolkit. Instead, they can use 
individual sections as needed. Summary materials 
are presented at the beginning, and more detailed 
information is in the appendix (Table 1).
The toolkit summarizes a triage model for 
approaching patient complaints related to ADHD. 
This model defines the role of primary care providers, 
behavioral health clinicians, and psychiatrists, 
and it depicts a decision tree that depends on the 
complexity of the patient’s presentation. Higher 
levels of complexity require more ancillary support, 
and the toolkit offers examples of when to refer 
patients to behavioral health specialists. Psychiatry 
contact information is specified, and phone 
consultation with a psychiatrist is available at all 
complexity levels.
The toolkit also contains a handout for providers 
that describes essential tips regarding diagnosing 
and treating ADHD in adulthood. The handout 
has an evaluation checklist and information on 
differential diagnoses to rule out. The checklist 
includes establishing whether the patient’s condition 
is chronic and onset in childhood, corroboration of 
the patient’s history, use of validated rating scales 
(e.g., the Conners’ Adult ADHD Rating Scales, 
Weiss Functional Impairment Rating Scale), and 
use of functional outcomes. Pharmacological 
and nonpharmacological treatment options are 
summarized (Table 2). A medication table with 
dosing instructions, Food and Drug Administration 
(FDA) indications, and Maine Medicaid preference 
status is included. Also, recommendations on safe 
prescribing practices for stimulants are given.
The toolkit also contains materials for patients. 
The Adult ADHD Info Sheet provides an overview 
of adult ADHD and information about signs and 
symptoms, causes, diagnosis, and treatment of the 
disorder. The Adult ADHD Resources Sheet lists 
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useful books, magazines, articles, websites, and 
podcasts.
The end of the toolkit contains an Appendix with 
more in-depth information about assessing and 
managing adult ADHD. This section offers further 
guidance on how to safely prescribe stimulants, 
what rating scales to use, and how to use the scales 
at different stages of treatment. It also contains 
information about approaching comorbidity with 
adult ADHD (e.g., mood disorders, anxiety disorders, 
substance use disorders, psychotic disorders), and 
an Assessment Worksheet that guides practitioners 
through a patient interview using pertinent adult-
oriented questions.
DISCUSSION
In developing the Adult ADHD Toolkit, concerted 
effort was put into tackling challenges commonly 
seen in adult ADHD (Table 1). To address concerns 
about the rise in nonmedical use of stimulants20, 
the toolkit underscores when stimulants are 
contraindicated, offers guidance on safe prescribing 
practices, and summarizes effective nonstimulant 
treatment options (Table 2). Nonstimulant treatments 
do not have secondary status in the toolkit. Rather, 
adult ADHD is a complex condition that requires an 
individualized treatment plan. Additionally, applying 
functional outcomes is recommended for monitoring 
a patient’s course and supporting the treatment 
plan, especially when stimulants are prescribed.
In the child/adolescent population, patient 
complaints are typically accompanied by parents’ 
and teachers’ concerns. Conversely, in adult-
focused practices, providers frequently rely solely 
on patient histories, which are often unreliable.8 To 
account for this challenge, the toolkit stresses the 
importance of corroborating a patient’s history. It 
also offers tips on accomplishing this task in a busy 
practice, such as using behavioral health clinicians 
and having informants complete rating scales 
designed for use in adult ADHD.
Several limitations exist related to the Adult ADHD 
Toolkit. For example, the literature contains limited 
quality research on ADHD in adulthood. Given 
the absence of head-to-head trials, knowing 
when and how to integrate pharmacological 
and nonpharmacological treatments is unclear. 
To overcome gaps in knowledge about best 
practices, the workgroup relied on consensus of 
each member’s clinical experience. A potential 
consequence of this approach is that the opinions 
of the workgroup may have been influenced by 
personal and group misconceptions of clinical 
norms. Additionally, because patient input was not 
sought in developing the toolkit, the toolkit may be 
suboptimal from a patient’s perspective. While more 
conservative recommendations around prescribing 
stimulants were established to minimize public-
health risk, some patients and providers may view 
these recommendations as restrictive.
The process of creating the Adult ADHD Toolkit 
presented an opportunity to begin asking and 
answering important questions about the clinical 
management of mental health conditions in 
collaborative care. For example, how can guidelines 
be optimally developed and disseminated across 
medical departments? A common request during 
in-service meetings has been whether the toolkit 
can be integrated into the electronic medical record 
(EMR). While this request is being evaluated, 
it is complicated by the use of different EMRs in 
the primary care and psychiatry specialties at 
MaineHealth.
Another question regarded whether implementation 
of the toolkit would affect provider perceptions of 
adult ADHD and/or prescribing practices. Answering 
this question could reveal how more complicated 
mental health conditions can be safely and 
effectively addressed within a collaborative care 
model. It can also help to flesh out more specific 
provider strengths and weaknesses related to adult 
ADHD. A quality improvement project underway at 
MaineHealth aims to answer this question.
CONCLUSIONS
ADHD in adulthood is more prevalent than ever and 
associated with a variety of negative outcomes for 
individuals and society. Collaborative care offers 
a unique opportunity to coordinate management 
of this complex condition between providers. The 
Adult ADHD Toolkit provides a framework to discern 
adult ADHD and assist with treatment planning 
for patients with complicated histories. The toolkit 
intends to help providers balance patient requests 
with safe and efficient practices. Because the toolkit 
cannot guarantee specific outcomes, discretion 
must be used in applying it to individual patients. 
More work is needed to determine the process for 
successfully implementing the toolkit, and whether 
it is useful and effective for providers and patients. 
If so, wider implementation of the toolkit will be 
considered.
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Table 1: Adult ADHD Toolkit Summary
Table of contents Topics addressed
Introduction Intent and limitations of the toolkitPsychiatry contact information
Triage Model
Collaborative care provider roles
Characteristics of low, moderate, and high complexity cases
When to refer a patient for additional care
Assessment and 
Treatment Overview
Basic assessment, treatment, and monitoring tips
Differential diagnosis of ADHD in adulthood
What rating scales to use and when
Treatment options with a supportive evidence base
How to use functional outcomes
How to know when treatment is working
Medication Table Medication dosing, FDA approval, and Medicaid coverageWhen to prescribe a nonstimulant vs. stimulant
Adult ADHD Info and 
Resources Sheets General information about adult ADHD and resources for patients
Appendix
Detailed assessment, treatment, and monitoring tips
Pros and cons of rating scales applicable to adults
Pertinent adult-oriented questions to use in an evaluation
Treatment planning for more complex cases
Safely prescribing stimulants
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Table 2. Treatment Options for Adult ADHD
Nonstimulant medications9,12,14 Nonstimulants are effective and can help with comorbid 
psychiatric symptoms, such as depression and anxiety. They can 
be used as monotherapy or with stimulants.
Stimulant medications9,12,14 Given the potential public health and individual risks, stimulants 
should be considered only after a thorough evaluation that rules 
out potential complications and contraindications. There are two 
categories of stimulants, methylphenidate- and amphetamine-
based, which have similar efficacy and tolerability. If a patient 
does not benefit from a stimulant in one category, a stimulant 
from the other category can be trialed.
Patient education15 Patient education is an essential part of managing adult ADHD. 
Independent of medication, duration of treatment, and outcome, 
the strongest predictor of patient satisfaction appears to be 
education received from providers.
Psychotherapy9,10,12,13 Psychotherapy is an effective treatment strategy, especially 
for patients who prefer psychotherapy, have an inadequate 
response to medication, or present with psychiatric comorbidity. 
Psychotherapists can help patients use adaptive problem-
solving techniques and offer cognitive reframing for symptoms 
of depression, anxiety, demoralization, procrastination, and 
perfectionism.
Vocational counseling16 Vocational counseling can help patients identify work strengths 
and weaknesses, find available job opportunities, address 
workplace challenges, and restructure their work environment to 
improve job performance.
Exercise17 Regular exercise provides physical and mental health benefits, 
and it helps to increase levels of brain-derived neurotrophic 
factor, a protein involved in learning and memory.
Diet11,14 Elimination diets may benefit patients with food sensitivities 
related to artificial coloring, gluten, dairy, nuts, and other 
offending ingredients.
Nutraceuticals11,12,18,19 Promising nutraceuticals include omega-3 fatty acids, pycnogenol 
(pine bark), valerian, passion flower, and ginseng.
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